Literature DB >> 1433011

Hyperferritinemia in adult onset Still's disease and the hemophagocytic syndrome.

M Coffernils1, A Soupart, O Pradier, W Feremans, P Nève, G Decaux.   

Abstract

Increments in serum ferritin levels in adult onset Still's disease (AOSD) were reported to be higher than one could expect for a simple inflammatory state. When we analyzed the scores of 40 patients with various severe inflammatory diseases aside from AOSD, we recorded no serum ferritin values higher than 3,300 ng/ml (N less than 200 ng/ml). In 3 of 10 consecutive patients with AOSD, the ferritin levels were higher than 3,500. Among these 3 patients, one case had a ferritin value of 3,600 ng/ml and bone marrow aspirate showed a marked hyperplasia of mature appearing histiocytes, and the 2 other patients (serum ferritin levels of 65,000 ng/ml and 250,000 ng/ml) displayed the features of a hemophagocytic syndrome. In 2 patients with normal or mildly increased levels of ferritin, the bone marrow examination was normal. We suggest that very high serum ferritin levels encountered in AOSD reflect the presence of histiocytic hyperactivity that sometimes leads to a hemophagocytic syndrome.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1433011

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  26 in total

1.  Therapeutic responses and prognosis in adult-onset Still's disease.

Authors:  Hyoun-Ah Kim; Jun-Mo Sung; Chang-Hee Suh
Journal:  Rheumatol Int       Date:  2011-01-29       Impact factor: 2.631

2.  A long story begun with a simple sore throat.

Authors:  Giuseppina Pisano; Paola Bonara; Paolo Rietti; Lorena Airaghi; Luigi Sinigaglia; Giovanni Boccoli; Larry Burdick; Marta del Medico; Edoardo Pulixi; Fabio Silini; Alessandra Gandolfi; Silvia Fargion
Journal:  Intern Emerg Med       Date:  2010-07-22       Impact factor: 3.397

3.  Extremely High Ferritinemia Associated with Haemophagocytic Lympho Histiocytosis (HLH).

Authors:  Neelima Verma; Jyoti Chakraverty; Pankaj Baweja; Alka Girotra; Leena Chatterjee; Manish Chugh
Journal:  Indian J Clin Biochem       Date:  2016-02-17

Review 4.  Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature.

Authors:  J-B Arlet; Thi Huong D Le; A Marinho; Z Amoura; B Wechsler; T Papo; J-C Piette
Journal:  Ann Rheum Dis       Date:  2006-03-15       Impact factor: 19.103

5.  Early diagnostic value of low percentage of glycosylated ferritin in secondary hemophagocytic lymphohistiocytosis.

Authors:  Zhao Wang; Yini Wang; Jingshi Wang; Cuicui Feng; Liping Tian; Lin Wu
Journal:  Int J Hematol       Date:  2009-08-05       Impact factor: 2.490

6.  Reactive hemophagocytic syndrome in a patient with polyarteritis nodosa associated with Epstein-Barr virus reactivation.

Authors:  Ikuko Hayakawa; Fumiaki Shirasaki; Hiroko Ikeda; Naoto Oishi; Minoru Hasegawa; Shinichi Sato; Kazuhiko Takehara
Journal:  Rheumatol Int       Date:  2006-04       Impact factor: 2.631

7.  [Adult-onset Still's disease, Schnitzler syndrome, and autoinflammatory syndromes in adulthood].

Authors:  P Lamprecht
Journal:  Z Rheumatol       Date:  2009-11       Impact factor: 1.372

8.  Spectrum of lymph node pathology in adult onset Still's disease; analysis of 12 patients with one follow up biopsy.

Authors:  Y K Jeon; J H Paik; S-S Park; S O Park; Y A Kim; J E Kim; Y W Song; C W Kim
Journal:  J Clin Pathol       Date:  2004-10       Impact factor: 3.411

9.  Fulminant hemophagocytic syndrome with a high interferon gamma level diagnosed as macrophage activation syndrome.

Authors:  Tsuyoshi Muta; Yujiro Yamano
Journal:  Int J Hematol       Date:  2004-06       Impact factor: 2.490

10.  Adult-onset Still's disease with disseminated intravascular coagulation and multiple organ dysfunctions dramatically treated with cyclosporine A.

Authors:  Jae-Hong Park; Joong Ho Bae; Yeon-Soo Choi; Hye-Soon Lee; Jae-Bum Jun; Sungsoo Jung; Dae-Hyun Yoo; Sang-Cheol Bae; Tae-Hwan Kim
Journal:  J Korean Med Sci       Date:  2004-02       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.